<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Sinerjistik tedavi &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/sinerjistik-tedavi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 08 Jan 2026 00:11:46 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Sinerjistik tedavi &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>RG3 and Cantharidin Combat Liver Cancer Together</title>
		<link>https://bioengineer.org/rg3-and-cantharidin-combat-liver-cancer-together/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jan 2026 00:11:24 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ginsenosid RG3 ve kantarisin]]></category>
		<category><![CDATA[Ginsenoside RG3]]></category>
		<category><![CDATA[Hepatosellüler karsinom]]></category>
		<category><![CDATA[Kantaridin]]></category>
		<category><![CDATA[lipid metabolizması]]></category>
		<category><![CDATA[PRMT1-SREBF1 ekseni]]></category>
		<category><![CDATA[sinerjistik kanser tedavisi]]></category>
		<category><![CDATA[Sinerjistik tedavi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/rg3-and-cantharidin-combat-liver-cancer-together/</guid>

					<description><![CDATA[Recent advancements in cancer research have illuminated the profound abilities of natural compounds to combat relentless diseases such as hepatocellular carcinoma (HCC). Among these promising agents are ginsenoside RG3 and cantharidin, both of which are stirring significant interest in the oncological community due to their potential synergistic effects. These compounds, derived from traditional medicinal resources, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314681</post-id>	</item>
	</channel>
</rss>
